{"id":4910,"date":"2014-01-13T14:22:03","date_gmt":"2014-01-13T13:22:03","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=4910"},"modified":"2014-01-13T14:22:03","modified_gmt":"2014-01-13T13:22:03","slug":"avaluacio-economica-de-medicaments-2","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/","title":{"rendered":"Estado de la evaluaci\u00f3n de los medicamentos en Catalu\u00f1a"},"content":{"rendered":"<p>\u00bfEn qu\u00e9 consiste la evaluaci\u00f3n econ\u00f3mica de medicamentos? \u00bfCu\u00e1l es la perspectiva actual? \u00bfC\u00f3mo se realiza en Espa\u00f1a y en Catalu\u00f1a la evaluaci\u00f3n? \u00c9stas son algunas de las preguntas que se respondieron a la conferencia \u201c<strong>Estado actual de la evaluaci\u00f3n de los medicamentos en Catalu\u00f1a<\/strong>\u201d que acogi\u00f3 el Colegio el 3 de diciembre.<\/p>\n<p>El acto, dirigido a farmac\u00e9uticos de atenci\u00f3n primaria y farmac\u00e9uticos de hospitales, fue coordinado por Julio Mart\u00ednez, jefe de farmacia del Vall d&#039;Hebron y presidente de la Sociedad Catalana de Farmacia Cl\u00ednica (SCFC); Tom\u00e0s Casas\u00edn, jefe de farmacia del Hospital de Viladecans y vocal de Hospitales del COFB, y Roser Vall\u00e9s, responsable Gesti\u00f3n Actividad Farmacia SAP Vall\u00e9s Occidental DAP Metropolitana Nord, ICS y vocal de Atenci\u00f3n Primaria del COFB.<\/p>\n<p>En primer lugar, el ponente Francesc Puigvent\u00f3s, fundador del Grupo Genesi, habl\u00f3 de <strong>la experiencia de evaluaci\u00f3n en la perspectiva actual.<\/strong> \u201cUno de los elementos m\u00e1s dif\u00edciles para realizar un informe de evaluaci\u00f3n es el precio\u201d, afirm\u00f3, al tiempo que destac\u00f3 la importancia de que el Ministerio facilite toda la informaci\u00f3n al respecto. &quot;Las comunidades aut\u00f3nomas est\u00e1n potenciando estructuras de evaluaci\u00f3n&quot;, coment\u00f3.<\/p>\n<p>El siguiente punto a tratar fue <strong>el rol de la Agencia de Calidad y Evaluaci\u00f3n Sanitarias de Catalu\u00f1a (AQuAS)<\/strong>\u00a0en la evaluaci\u00f3n de medicamentos, a cargo de la farmac\u00e9utica Ana Maria de Andr\u00e9s. AQuAS es una empresa p\u00fablica adscrita al Departamento de Salud de la Generalitat y su principal cliente, en el \u00e1mbito de la farmacia, es CatSalut. Su labor est\u00e1 focalizada en la evaluaci\u00f3n, y como explica De Andr\u00e9s, se realiza teniendo en cuenta tres vertientes: las tecnolog\u00edas m\u00e9dicas, los medicamentos y la investigaci\u00f3n.<\/p>\n<p>Por \u00faltimo, Tatiana Dilla, gerente de farmacoeconom\u00eda de Lilly, patrocinador de la conferencia, se centr\u00f3 en\u00a0<strong>la evaluaci\u00f3n econ\u00f3mica de medicamentos en Espa\u00f1a, su situaci\u00f3n actual y sus perspectivas de futuro.<\/strong>\u00a0&quot;El resultado final de cualquier evaluaci\u00f3n econ\u00f3mica es el coste efectividad incremental&quot;. &quot;A su vez -prosigui\u00f3 Dilla- para poder realizar bien esta evaluaci\u00f3n se necesitan recursos humanos, profesionales especializados y recursos econ\u00f3micos&quot;.<\/p>\n<h6 style=\"text-align: right;\"><strong>Con el patrocinio de:\u00a0<\/strong><\/h6>\n<p><img decoding=\"async\" class=\"alignright\" alt=\"\" src=\"http:\/\/www.cofb.net\/image\/image_gallery?img_id=1800&amp;large=1&amp;key=361640\" \/><\/p>","protected":false},"excerpt":{"rendered":"<p>\u00bfEn qu\u00e9 consiste la evaluaci\u00f3n econ\u00f3mica de medicamentos? \u00bfCu\u00e1l es la perspectiva actual? \u00bfC\u00f3mo se realiza en Espa\u00f1a y en Catalu\u00f1a la evaluaci\u00f3n? \u00c9stas son algunas de las preguntas que se respondieron a la conferencia \u201cEstado actual de la evaluaci\u00f3n de los medicamentos en Catalu\u00f1a\u201d que acogi\u00f3 el Colegio el 3 de [\u2026]<\/p>","protected":false},"author":1,"featured_media":4920,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[938,70,481],"class_list":["post-4910","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-atencio-primaria","tag-formacio","tag-hospitals"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Estat de l&#039;avaluaci\u00f3 dels medicaments a Catalunya - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Estat de l&#039;avaluaci\u00f3 dels medicaments a Catalunya - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"En qu\u00e8 consisteix l&#8217;avaluaci\u00f3 econ\u00f2mica de medicaments? Quina \u00e9s la perspectiva actual? Com es realitza a Espanya i a Catalunya l&#8217;avaluaci\u00f3? Aquestes s\u00f3n algunes de les preguntes que es van respondre a la confer\u00e8ncia &#8220;Estat actual de l&#8217;avaluaci\u00f3 dels medicaments a Catalunya&#8221; que va acollir el Col\u00b7legi el 3 de [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-01-13T13:22:03+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Estat de l&#8217;avaluaci\u00f3 dels medicaments a Catalunya\",\"datePublished\":\"2014-01-13T13:22:03+00:00\",\"dateModified\":\"2014-01-13T13:22:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/\"},\"wordCount\":399,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Atenci\u00f3 prim\u00e0ria\",\"Formaci\u00f3\",\"Hospitals\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/\",\"name\":\"Estat de l'avaluaci\u00f3 dels medicaments a Catalunya - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2014-01-13T13:22:03+00:00\",\"dateModified\":\"2014-01-13T13:22:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Estat de l&#8217;avaluaci\u00f3 dels medicaments a Catalunya\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Estat de l'avaluaci\u00f3 dels medicaments a Catalunya - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/","og_locale":"es_ES","og_type":"article","og_title":"Estat de l'avaluaci\u00f3 dels medicaments a Catalunya - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"En qu\u00e8 consisteix l&#8217;avaluaci\u00f3 econ\u00f2mica de medicaments? Quina \u00e9s la perspectiva actual? Com es realitza a Espanya i a Catalunya l&#8217;avaluaci\u00f3? Aquestes s\u00f3n algunes de les preguntes que es van respondre a la confer\u00e8ncia &#8220;Estat actual de l&#8217;avaluaci\u00f3 dels medicaments a Catalunya&#8221; que va acollir el Col\u00b7legi el 3 de [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2014-01-13T13:22:03+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Estat de l&#8217;avaluaci\u00f3 dels medicaments a Catalunya","datePublished":"2014-01-13T13:22:03+00:00","dateModified":"2014-01-13T13:22:03+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/"},"wordCount":399,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#primaryimage"},"thumbnailUrl":"","keywords":["Atenci\u00f3 prim\u00e0ria","Formaci\u00f3","Hospitals"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/","url":"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/","name":"Estat de l'avaluaci\u00f3 dels medicaments a Catalunya - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#primaryimage"},"thumbnailUrl":"","datePublished":"2014-01-13T13:22:03+00:00","dateModified":"2014-01-13T13:22:03+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2014\/01\/13\/avaluacio-economica-de-medicaments-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Estat de l&#8217;avaluaci\u00f3 dels medicaments a Catalunya"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"En qu\u00e8 consisteix l&#8217;avaluaci\u00f3 econ\u00f2mica de medicaments? Quina \u00e9s la perspectiva actual? Com es realitza a Espanya i a Catalunya l&#8217;avaluaci\u00f3? Aquestes s\u00f3n algunes de les preguntes que es van respondre a la confer\u00e8ncia &#8220;Estat actual de l&#8217;avaluaci\u00f3 dels medicaments a Catalunya&#8221; que va acollir el Col\u00b7legi el 3 de [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/4910","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=4910"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/4910\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=4910"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=4910"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=4910"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}